NASDAQ:ACRS

Aclaris Therapeutics SEC Filings & 10K Form

$27.20
+0.74 (+2.80 %)
(As of 04/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$26.62
Now: $27.20
$28.25
50-Day Range
$21.14
MA: $25.22
$29.60
52-Week Range
$1.02
Now: $27.20
$30.38
Volume509,930 shs
Average Volume2.57 million shs
Market Capitalization$1.41 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.2

SEC Filings

Aclaris Therapeutics (NASDAQ:ACRS) SEC Filings

DateFilerForm TypeView
03/03/2021
7:42 PM
Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:39 PM
Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:36 PM
Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:32 PM
Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
6:33 AM
Aclaris Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2021
6:15 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2021
1:56 PM
Aclaris Therapeutics (Subject)
Foresite Capital Fund III, L.P. (Filed by)
Form SC 13G/A
02/11/2021
6:29 AM
Aclaris Therapeutics (Subject)
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Form SC 13G/A
02/10/2021
5:00 PM
Aclaris Therapeutics (Issuer)
Foresite Capital Fund III, L.P. (Reporting)
Foresite Capital Fund IV, L.P. (Reporting)
Foresite Capital Fund V, L.P. (Reporting)
Foresite Capital Management III, LLC (Reporting)
Foresite Capital Management IV, LLC (Reporting)
Foresite Capital Management V, LLC (Reporting)
Tananbaum James B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/03/2021
4:33 PM
Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
4:29 PM
Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
4:26 PM
Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
4:23 PM
Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2021
7:45 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/20/2021
4:00 PM
Aclaris Therapeutics (Filer)
Form 424B5
01/20/2021
6:18 AM
Aclaris Therapeutics (Filer)
Form S-3MEF
01/19/2021
3:04 PM
Aclaris Therapeutics (Filer)
Form 424B5
12/17/2020
4:08 PM
Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
4:07 PM
Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
4:06 PM
Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2020
6:16 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2020
6:32 AM
Aclaris Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2020
6:15 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/26/2020
3:49 PM
Aclaris Therapeutics (Subject)
Aclaris Therapeutics (Subject)
Rock Springs Capital Management LP (Filed by)
Form SC 13G
09/15/2020
6:05 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2020
3:23 PM
Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2020
4:18 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2020
4:28 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2020
4:26 PM
Aclaris Therapeutics (Filer)
Form 424B5
08/07/2020
6:31 AM
Aclaris Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2020
6:16 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2020
2:04 PM
Aclaris Therapeutics (Subject)
MFN Partners Management, LP (Filed by)
Form SC 13G/A
07/07/2020
6:25 PM
Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2020
3:25 PM
Aclaris Therapeutics (Subject)
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Form SC 13G
06/24/2020
4:00 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2020
6:16 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2020
4:46 PM
Aclaris Therapeutics (Issuer)
Reasons Bryan M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
4:45 PM
Aclaris Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
4:31 PM
Aclaris Therapeutics (Issuer)
Molineaux Christopher P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
4:30 PM
Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
4:29 PM
Aclaris Therapeutics (Issuer)
Humphries William D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
4:28 PM
Aclaris Therapeutics (Issuer)
Powell Andrew Kenneth William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
4:27 PM
Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2020
4:24 PM
Aclaris Therapeutics (Issuer)
MILANO VINCENT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2020
3:42 PM
Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2020
6:03 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2020
6:04 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2020
3:31 PM
Aclaris Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2020
11:15 PM
Aclaris Therapeutics (Filer)
Form EFFECT
04/23/2020
6:05 AM
Aclaris Therapeutics (Filer)
Form DEFA14A
04/23/2020
6:01 AM
Aclaris Therapeutics (Filer)
Form DEF 14A
04/07/2020
8:34 PM
Aclaris Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
03/31/2020
3:15 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2020
3:21 PM
Aclaris Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/25/2020
3:15 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
12:49 PM
Aclaris Therapeutics (Subject)
Rock Springs Capital Management LP (Filed by)
Form SC 13G/A
02/13/2020
4:19 PM
Aclaris Therapeutics (Subject)
Broadfin Capital, LLC (Filed by)
Form SC 13G/A
02/13/2020
3:53 PM
Aclaris Therapeutics (Subject)
MFN Partners Management, LP (Filed by)
Form SC 13G/A
02/13/2020
11:36 AM
Aclaris Therapeutics (Subject)
Flynn James E (Filed by)
Form SC 13G/A
02/13/2020
9:38 AM
Aclaris Therapeutics (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G/A
02/04/2020
6:13 PM
Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
6:12 PM
Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
6:11 PM
Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
1:25 PM
Aclaris Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SC 13G/A
01/13/2020
6:04 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2020
3:39 PM
Aclaris Therapeutics (Issuer)
MILANO VINCENT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2020
3:34 PM
Aclaris Therapeutics (Issuer)
MILANO VINCENT (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2020
7:15 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2019
3:19 PM
Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2019
4:15 PM
Aclaris Therapeutics (Subject)
Arkin Moshe (Filed by)
Form SC 13D/A
12/18/2019
10:04 AM
Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2019
10:02 AM
Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2019
10:00 AM
Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2019
3:48 PM
Aclaris Therapeutics (Subject)
Arkin Moshe (Filed by)
Form SC 13D/A
11/21/2019
6:01 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2019
4:01 PM
Aclaris Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2019
3:16 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2019
4:26 PM
Aclaris Therapeutics (Subject)
MFN Partners Management, LP (Filed by)
Form SC 13G
10/31/2019
3:18 PM
Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
8:54 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2019
4:00 PM
Aclaris Therapeutics (Subject)
Arkin Moshe (Filed by)
Form SC 13D
10/10/2019
8:39 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2019
6:01 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2019
6:30 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2019
7:45 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2019
3:22 PM
Aclaris Therapeutics (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G
08/08/2019
4:01 PM
Aclaris Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
3:15 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2019
6:18 AM
Aclaris Therapeutics (Subject)
Flynn James E (Filed by)
Form SC 13G/A
07/30/2019
3:15 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2019
3:33 PM
Aclaris Therapeutics (Subject)
Rock Springs Capital Management LP (Filed by)
Form SC 13G
07/09/2019
4:11 PM
Aclaris Therapeutics (Subject)
Man Group plc (Filed by)
Form SC 13G
07/03/2019
3:47 PM
Aclaris Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
3:46 PM
Aclaris Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2019
3:44 PM
Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
3:15 PM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2019
4:01 PM
Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
4:52 PM
Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
5:31 PM
Aclaris Therapeutics (Issuer)
DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Special Situations Fund, L.P. (Reporting)
Flynn James E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
5:15 AM
Aclaris Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 4/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.